Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for spontaneous-breathing uniportal thoracoscopic pulmonary surgery under laryngeal mask airway
ChiCTR2000040584Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in postoperative pain, Perioperative anxiety and major depressive disorder (MDD) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Perioperative opioid use and postoperative analgesia pump use and Hemodynamics and arterial blood gas changes. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painPerioperative anxietymajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2000040584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040584.